Kolon Life Science Inc. (KOSDAQ:102940)
31,500
-450 (-1.41%)
Aug 8, 2025, 3:30 PM KST
Kolon Life Science Revenue
Kolon Life Science had revenue of 44.83B KRW in the quarter ending March 31, 2025, with 16.27% growth. This brings the company's revenue in the last twelve months to 167.66B, up 27.19% year-over-year. In the year 2024, Kolon Life Science had annual revenue of 161.39B with 29.48% growth.
Revenue (ttm)
167.66B
Revenue Growth
+27.19%
P/S Ratio
2.37
Revenue / Employee
393.57M
Employees
426
Market Cap
396.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 161.39B | 36.75B | 29.48% |
Dec 31, 2023 | 124.64B | -36.94B | -22.86% |
Dec 31, 2022 | 161.58B | -3.90B | -2.36% |
Dec 31, 2021 | 165.49B | 36.07B | 27.87% |
Dec 31, 2020 | 129.41B | -19.13B | -12.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
HD Hyundai Heavy Industries | 15.32T |
KB Financial Group | 15.69T |